4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: May 4, 2012
Period of Report: May 2, 2012
Accession Number: 0001144204-12-026347

View Document ↗ View on SEC.gov ↗